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Supplementary Materials and Methods 
siRNA sequences 
The sequences of the siRNAs used are as follows: Satb1 siRNA 1–
AAGGTGGTACAAACATTTCAA, Satb1 siRNA 2– CAGGAAATGAAGCGTGCTAAA, Satb1 
siRNA 3 – CCCGAAGTACACCATCATCAA, Satb2 siRNA 1 – 
CCGAAGGACTAGACTGTGAA, Satb2 siRNA 2-ATGGCCCATCTGATAAACCAA, Satb2 
siRNA 3–CAGGGATTATTGTCAGAGATA. 
Immunofluorescence protocol and intensity measurements and antibody details 
ICM cells were identified through sequential scanning through embryo z-stacks by their 
position as well as through the use of lineage markers. Nanog expressing cells in the ICM 
that did not express PE markers were identified as EPI. Inside and outside cells were 
identified by careful scanning through the z-stack. Only in cases when outer (with nuclei that 
were not surrounded by other cells and adjacent to the outside of the embryo) and inner (with 
nuclei that were entirely surrounded by other cells) cells could be unambiguously identified 
where they used for analyses. Fluorescence intensity was quantified by normalising to DAPI 
and layer-normalising using the built-in IMAGEJ function. Intensity measurements were done 
on the normalised sections using the IMAGEJ measure function. For antibody details see 
Supplementary Materials and Methods. Primary antibodies used: goat anti-Sox17 (1:200; 
R&D Systems, AF1924), goat anti-Pdgfrα (1:200; Santa Cruz, sc-31178), goat anti-Gata6 
(1:200; R&D Systems, AF1700), rabbit anti-Nanog (1:200; Abcam, AB80892), rabbit anti-
Sox2 (1:200; Abcam, ab59776), rabbit anti-Sox2 (1:200; Millipore, AB5603) mouse anti-Cdx2 
(1:200; Biogenex, AM392), rabbit anti-Satb1 (1:50; Abcam, AB49061), rabbit anti-Satb2 
(1:200; Abcam, AB34735), rat anti-Nanog (1:200; Ebiosciences, 14-5761-80). Secondary 
antibodies used: Alexa Fluor 647 donkey anti-mouse IgG, Alexa Fluor 568 donkey anti-goat 
IgG, Alexa Fluor 568 donkey anti-rabbit IgG, Alexa Fluor 647 donkey anti-rabbit IgG, Alexa 
Fluor 647 donkey anti-goat IgG, Alexa Fluor 647 phalloidin. 
Primer details 
The following primers were used all written 5’-3’: Gapdh Forward, 
AGAGACGGCCGCATCTTC, Reverse, CCCAATACGGCCAAATCCGT';  Histone H2A.Z 
Forward, CGTCAGAGAGACGCTTACCG, Reverse, AAGCCTCCAACTTGCTCAAA; Satb1 
Forward, AGTGCCCCCTTTCACAGAG, Reverse, TGCTGCTGAGACATTTGCAT; Satb2 
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Forward, ATGAACCCCAATGTGAGCAT, Reverse, GTTGTCGGTGTCGAGGTTTT; Cdx2 
Forward, AAACCTGTGCGAGTGGATG, Reverse, TCTGTGTACACCACCCGGTA; Nanog 
Forward, GGTTGAAGACTAGCAATGGTCTGA, Reverse, TGCAATGGATGCTGGGATACT; 
Oct3 Forward, TTGGGCTAGAGAAGGATGTGGTT, Reverse, 
GGAAAAGGGACTGAGTAGAG TGTGG; Sox2 primer set 1 Forward, 
GCGGAGTGGAAACTTTTGTCC, Reverse, CGGGAAGCGTGTACTTATCCTT; Sox2 primer 
set 2 Forward, GCGGAGTGGAAACTTTTGTCC Reverse, 
GGGAAGCGTGTACTTATCCTTCT; Sox17 Forward, GATGCGGGATACGCCAGTG, 
Reverse, CCACCACCTCGCCTTTCAC; Id2 Forward, ATGAAAGCCTTCAGTCCGGTG, 
Reverse, AGCAGACTCATCGGGTCGT; Gata6 Forward,  TTGCTCCGGTAACAGCAGTG, 
Reverse, GTGGTCGCTTGTGTAGAAGGA 
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Figure S1. Confirmation of Satb1 siRNA persistence and specificity and Satb1 embryo staining. A)
Immunofluorescence of Satb1 in 8-cell embryos (n=25). Embryo boundary is outlined in white. B)
Quantification of immunofluorescence represented in A. Fluorescence quantified and normalized to the
nucleus with the strongest staining per individual embryo. C) Immunofluorescence of Satb1 in early
blastocysts after being injected with control (n=14) or Satb1 siRNA (n=18). D) Quantification of relative
fluorescent intensity of Satb1 staining from C. E) Confocal images of control and Satb1 siRNA 1, Satb1
siRNA 2 and Satb1 siRNA 3 injected embryos. Nanog, (EPI), Sox17 (PE) and Cdx2 (TE) were used as
lineage markers. Quantification of this experiment shown in F.F) Contribution of control (n=17) and Satb1
siRNA 1 (n=19),2 (n=21), and 3 (n=23) injected embryos to EPI, PE, and TE. G) qRT–PCR of control (n=47
embryos, three biological repeats), Satb1 siRNA 1 (n=58 embryos, three biological repeats), Satb1 siRNA 2
(n=53 embryos, three biological repeats), Satb1 siRNA 3 (n=49 embryos, three biological repeats) injected
embryos to investigate Satb1 mRNA levels.
Student’s t-test was used to test significance *= p<0.05, **= p<0.01, ***= p<0.001. Error bars represent
s.e.m. Scale bars, 10 μm.
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Figure S2. Z-stack slices of confocal images from Figure 2E. A) Slices of the
confocal z-stack of the control siRNA injected embryo presented in Fig 2 E.
Nanog, (EPI), Sox17 (PE) and Cdx2 (TE) were used as lineage markers B) Slices
of the confocal Z-stack of the Satb1 siRNA injected embryo presented in Fig 2 E
(Embryo 1). Nanog, (EPI), Sox17 (PE) and Cdx2 (TE) were used as lineage
markers.
Scale bars, 10 μm.
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Figure S3. Satb1 siRNA phenotype assessed by Sox2, Gata6 and Pdgfrα. A) Confocal
images of control (n=31) and Satb1 siRNA (n=30) injected embryos. Sox2, (EPI), Gata6 (PE)
and Cdx2 (TE) were used as lineage markers. B) Contribution of control and Satb1 siRNA
injected embryos represented in A to EPI, PE, and TE. C) Confocal images of control (n=27)
and Satb1 siRNA (n=29) injected embryos. Sox2, (EPI), Pdgfrα (PE) and Cdx2 (TE) were used
as lineage markers. D) Contribution of control and Satb1 siRNA injected embryos represented
in C to EPI, PE, and TE.
Student’s t-test was used to test significance *= p<0.05, **= p<0.01. Error bars represent
s.e.m. Scale bars, 10 μm.
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Figure S4. Timing of effect of Satb1 RNAi. A) Confocal images of control (n=15) and Satb1
siRNA (n=21) injected embryos at the 16-cell stage showing the localisation and distribution of
Cdx2, Gata6 and Nanog. B) Relative number of blastomeres that are positive for Cdx2, Nanog
and Gata6 from control and Satb1 siRNA injected embryos represented in A. C) Confocal
images of control (n=17) and Satb1 siRNA (n=19) injected embryos at the 32-cell stage
showing the localisation and distribution of Cdx2, Gata6 and Nanog. D) Relative number of
blastomeres that are positive for Cdx2, Nanog and Gata6 from control and Satb1 siRNA
injected embryos represented in C. E) Confocal images of control (n=19) and Satb1 siRNA
(n=28) injected embryos at the early blastocyst stage showing the localisation and distribution
of Cdx2, Gata6 and Nanog. F) Relative number of blastomeres that are positive for Cdx2,
Nanog and Gata6 from control and Satb1 siRNA injected embryos represented in E.
Student’s t-test was used to test significance *= p<0.005,***= p<0.001. Error bars represent
s.e.m. Scale bars, 10 μm.
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Figure S5. Rescue of Satb1 siRNA phenotype by Satb1 mRNA. A) Scheme of
Satb1 rescue experiment shown in B and C. Zygotes were injected with Satb1 siRNA
or control siRNA. At the 2-cell stage both blastomeres were then injected with either
Satb1 mRNA or Ruby mRNA as a control and then cultured until E4.5. B) Confocal
images of control siRNA (n=12), Satb1 siRNA (n=21) and Satb1 siRNA + Satb1
mRNA (n=26) injected embryos. Nanog (EPI), Sox17 (PE) and Cdx2 (TE) were used
as lineage markers. C) Contribution of Satb1 siRNA and Satb1 siRNA + Satb1 mRNA
injected embryos to TE, PE and EPI, relative to control siRNA injected cells from
experiment shown in B.
Student’s t-test was used to test significance **= p<0.01, ***= p<0.001. Error bars
represent s.e.m. Scale bar, 10 μm.
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Figure S6. Effect of Satb1 and Satb2 overexpression on Satb1 and Satb2
mRNA levels. qRT–PCR of control (n=63 embryos, three biological repeats),
Satb1 (n=71 embryos, three biological repeats), Satb2 (n=58 embryos, three
biological repeats), Satb1 + Satb2 (n=47 embryos, three biological repeats)
mRNA injected embryos to investigate Satb1 and Satb2 mRNA levels.
Student’s t-test was used to test significance **= p<0.01, ***= p<0.001. Error
bars represent s.e.m. Scale bar, 10 μm.
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Figure S7. Satb1 expression pattern in blastocysts. A) Confocal images of Satb2
and Nanog staining in early blastocysts (n=12). A’) Confocal images of Satb2 and
Nanog staining in late blastocysts (n=16). Yellow arrows indicate EPI cells positive for
Satb2 . White asterisks indicate PE cells positive for Satb2. B) Quantification of relative
fluorescent intensity of Satb2 staining in EPI cells compared to PE/TE cells in late
blastocysts as shown in A’. EPI cells were identified by the expression of Nanog.
Scale bars, 10 μm.
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